William D. McClellan Jr., Director at REATA PHARMACEUTICALS INC (RETA), sold 5,000 shares at $164.49 ($822K) on 2023-07-28, disclosed to the SEC on 2023-08-01.
Scheduled sale ($822k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| APEN | BUY | 2017-05-30 | $13K | — | Filing → |
| APEN | BUY | 2017-05-18 | $11K | — | Filing → |